Sodium zirconium cyclosilicate in hyperkalemia. - Wikidata - wikimedia - TriplyDB

Sodium zirconium cyclosilicate in hyperkalemia.

Sodium zirconium cyclosilicate in hyperkalemia.

http://www.wikidata.org/entity/Q34448992

about

Pharmacological interventions for the acute management of hyperkalaemia in adults Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management Recent advances in treatment of heart failure Optimizing haemodialysate composition Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure Stop chronic kidney disease progression: Time is approaching Characterization of structure and function of ZS-9, a K+ selective ion trap Updates in hyperkalemia: Outcomes and therapeutic strategies.Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36 Advances in treatment of hyperkalemia in chronic kidney disease.Acute hyperkalemia leading to flaccid paralysis: a review of hyperkalemic manifestations The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease Hypertension Management in Diabetic Kidney Disease Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients.Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD Potassium-Binding Agents for the Clinical Management of Hyperkalemia.Potassium and Its Discontents: New Insight, New Treatments Novel Bloodless Potassium Determination Using a Signal-Processed Single-Lead ECG Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.An electronic alert to decrease Kayexalate ordering.Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review.Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease.Potential New Agents for the Management of Hyperkalemia.Dual Renin-Angiotensin-Aldosterone System Inhibition for the Treatment of Diabetic Kidney Disease: Adverse Effects and Unfulfilled Promise.How Dangerous Is Hyperkalemia?A retrospective study of emergency department potassium disturbances: severity, treatment, and outcomes.Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure.Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia.Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.Potassium: friend or foe?New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.Calibrating the impact of dual RAAS blockade on the heart and the kidney - balancing risks and benefits.Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia.Managing Hyperkalemia: Stepping Into a New Frontier.

P2860

Q24186355-79B57271-CC47-4000-8A37-2F70DA56E357 Q26765228-C4449F15-5B85-47E8-97E6-9B80C5D3B933 Q26766223-90ABE576-72ED-416F-850C-2D76D019FC33 Q26785879-8A25CD78-18F5-4AD9-9E3E-5F25C6E6036A Q26795398-187C15FB-2A00-49FD-B1ED-C5BDC3FE5037 Q26796378-248F037E-10BF-4BA8-825A-CC4128A4CFB9 Q28078020-6A364A0A-BA28-4A1A-A783-8443CF3AB402 Q28542799-893B62B0-BF36-43F7-8F41-232E63F8E783 Q30245585-E21F3B60-A47B-45BB-89A5-3FE87510440D Q30250020-ED03CB46-6328-4995-AC9F-24EBA80C9FE1 Q33620311-B00D1FDE-D17C-4352-8057-4573185B135C Q34491934-A535ADF1-9A3C-4357-96FA-4556FB7C5947 Q35762203-6D497804-6592-4041-89AB-1B97C0851A78 Q35914820-765F7F5D-9120-4F78-AA3F-F28E86A15B69 Q35953909-F0234EAE-0725-40B3-8481-19C75244B4DA Q36318268-A120F4D7-50C0-47B7-AF2A-499397D0FA17 Q36349441-8B27022E-2496-4275-8743-3C5E954D3F22 Q36425315-322A5DF8-FF17-4640-A34A-40D789410AA9 Q36746113-0F560171-3558-42B0-B79E-5B0857A3A356 Q36877800-B4E13C48-50F6-4471-AEC8-2FD4ADB3DAFE Q37275785-73F39C67-BF0D-465B-876B-2522CD7D2C33 Q37420987-25922EC3-680D-4CBC-9312-0C542A7D25F8 Q37722892-9DDC4CFE-AFE8-4248-AD88-63E2EB305FB1 Q38533385-1CCE2292-BA6B-485C-A22B-B4B2BCD1E181 Q38544101-E421FFDE-5DF4-40F3-8D2F-BC9AB887410E Q38566920-8BF1AA27-B9C0-446D-818F-63A6E27DD025 Q38639874-F2507663-43DC-449E-9C53-831EB5CACE3E Q38674568-2D2311DB-88B6-47DF-8B74-AB6C69CE435E Q38734501-DB8D0E20-213A-4FE3-AD01-229AADE3B64B Q38766590-3D3098A7-07B7-46E8-AD90-FA44B7422819 Q38777543-BBE33750-D45B-4E62-8ADB-34D131A6F540 Q38783092-D87E33D3-58C4-4CB3-BE01-5617C840FF94 Q38786625-1717F7D5-B0C2-4CD5-B78E-08A331B3FA76 Q38806963-2F1E08BA-C5F5-4E32-9CBF-342429DDB4EC Q38838019-7EFBCDFF-C0CB-4777-ACFB-3620E5636BD9 Q38845433-C9C080E9-BD3C-45D8-8954-5F646248E02B Q38859432-00749ADC-AE06-45F1-A5DD-3C1463CC1157 Q38859478-F07C5C53-1B69-4BD4-A7E4-D3F67C2B6BD3 Q38890685-2ACF4668-E194-469F-BC14-36BCD64EDABB Q38949822-BF3F0BA9-F937-4343-9102-22BF9CF10126

P2860

Sodium zirconium cyclosilicate in hyperkalemia.

http://www.wikidata.org/entity/Q34448992

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sodium zirconium cyclosilicate in hyperkalemia.

@ast

Sodium zirconium cyclosilicate in hyperkalemia.

@en

Sodium zirconium cyclosilicate in hyperkalemia.

@nl

type

label

Sodium zirconium cyclosilicate in hyperkalemia.

@ast

Sodium zirconium cyclosilicate in hyperkalemia.

@en

Sodium zirconium cyclosilicate in hyperkalemia.

@nl

prefLabel

Sodium zirconium cyclosilicate in hyperkalemia.

@ast

Sodium zirconium cyclosilicate in hyperkalemia.

@en

Sodium zirconium cyclosilicate in hyperkalemia.

@nl

P1433

Q34448992-62E64FA9-6372-4D0E-A797-1BD1DCD1EA7E

P1476

Q34448992-BE0991B7-10E3-41ED-A030-11D2DB5098F8

P2093

Q34448992-158343C0-3994-4978-95B5-80E231FA3F77

Q34448992-1B50FC82-C41F-4388-ABB8-0DCEBCEDC9EC

Q34448992-2027EFA2-3E25-4398-9DB4-EABE012FDE19

Q34448992-2C55FB4A-B34D-465A-A43A-412F8663BFF3

Q34448992-781C82CE-F91F-4F8E-8B5E-EE9EABE37EA3

Q34448992-A8987ECE-02AA-4A00-8677-6B0CFAB8213C

Q34448992-B6E528CB-F30F-47F3-9470-E86C1A71BE9F

Q34448992-BAA31238-4EB5-4A8A-83D5-629B02CB0259

Q34448992-BF7EA54E-EA41-4378-AC97-88E2BAE2AAE8

P304

Q34448992-D055D9AC-DF0D-4388-AE2A-E5EB11F63546

P31

Q34448992-121E7424-44F1-4E70-B94E-A8E7B7D76F8A

P356

Q34448992-B497A55A-09C4-4C3D-BC2B-4B867394376D

P407

Q34448992-3D94C193-C060-4D94-9AFB-152994590168

P433

Q34448992-C33EA65C-B473-46F4-B9CB-D9884F39636D

P478

Q34448992-D99C1298-69AE-4CB0-B2C1-E939B82F4876

P577

Q34448992-73D18A43-BDDD-456C-9A63-B06FBB3B0A70

P5875

Q34448992-1F8FC729-A52F-4C79-94C4-A09FEF4F845A

P698

Q34448992-E608267C-EB59-4E30-A42A-8E137228ABE2

P356

P1433

The New England Journal of Medicine

P1476

Sodium zirconium cyclosilicate in hyperkalemia.

@en

P2093

Bhupinder Singh

http://www.w3.org/2001/XMLSchema#string

David K Packham

http://www.w3.org/2001/XMLSchema#string

Geoffrey Block

http://www.w3.org/2001/XMLSchema#string

Henrik S Rasmussen

http://www.w3.org/2001/XMLSchema#string

Mohamed A El-Shahawy

http://www.w3.org/2001/XMLSchema#string

Pablo Pergola

http://www.w3.org/2001/XMLSchema#string

Philip T Lavin

http://www.w3.org/2001/XMLSchema#string

Simon D Roger

http://www.w3.org/2001/XMLSchema#string

Wajeh Qunibi

http://www.w3.org/2001/XMLSchema#string

P304

222-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1411487

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268790170

http://www.w3.org/2001/XMLSchema#string

P698

25415807

http://www.w3.org/2001/XMLSchema#string